PRESS STATEMENTS

10.28.2015

Pfizer Joins Broad Effort to Observe National Disability Employment Awareness Month

10.13.2015

Pfizer Expands Support for Patients with Gaucher Disease Through New Agreement for ELELYSO

07.17.2015

FDA Accepted For Review Pfizer NDA for ADHD Treatment

07.10.2015

Pfizer Applauds House of Representatives for Passing the 21st Century Cures Act

06.11.2015

Pfizer Wins Jury Verdict in Zoloft Case in Philadelphia

05.21.2015

Pfizer Applauds the Committee on Energy and Commerce for Passing the 21st Century Cures Act Today

04.30.2015

Pfizer Praises Passage Of New Alabama Legislation

10.16.2014

Statement Regarding FDA Advisory Committees’ Vote on CHANTIX®

05.07.2014

The Benefits of a Potential Combination with AstraZeneca PLC ("AstraZeneca")

02.06.2014

U.S. Appeals Court Upholds Lyrica Patent That Expires On December 30, 2018

10.07.2013

Bridget Walsh Appointed Vice President of Federal Government Relations

09.25.2013

Pfizer subsidiary Meridian awarded government contract to develop auto-injector medical countermeasure against nerve agent exposure

07.24.2013

Pfizer Statement on PhRMA-EFPIA Principles for Responsible Clinical Trial Data Sharing

07.02.2013

Pfizer Mourns Loss of Prominent Leader and Respected Board Member

03.19.2013

Pfizer Responds to New York Times Article on NIH Policy

03.18.2013

Original Statement Provided to New York Times

03.15.2013

Pfizer Response To Global Consensus Statement On Menopausal Hormone Therapy

03.12.2013

Zithromax (azithromycin) FDA Drug Safety Communication

11.29.2012

Pfizer Chairman and Chief Executive Officer Ian Read Issues Statement on White House Meeting

10.24.2012

Pfizer Donates Vials of Factor IX to the World Federation of Hemophilia to Help Developing Countries